Articoli con mandati relativi all'accesso pubblico - Nicholas P Restifo, MDUlteriori informazioni
Non disponibile pubblicamente: 1
141 The Role of T Memory Stem Cells: Pathogenesis and Vaccines
DE Lugli, L Gattinoni, NP Restifo, M Roederer
JAIDS Journal of Acquired Immune Deficiency Syndromes 59, 59, 2012
Mandati: US National Institutes of Health
Disponibili pubblicamente: 183
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy
SA Rosenberg, JC Yang, RM Sherry, US Kammula, MS Hughes, ...
Clinical cancer research 17 (13), 4550-4557, 2011
Mandati: US National Institutes of Health
Adoptive cell transfer as personalized immunotherapy for human cancer
SA Rosenberg, NP Restifo
Science 348 (6230), 62-68, 2015
Mandati: US National Institutes of Health
A human memory T cell subset with stem cell–like properties
L Gattinoni, E Lugli, Y Ji, Z Pos, CM Paulos, MF Quigley, JR Almeida, ...
Nature medicine 17 (10), 1290-1297, 2011
Mandati: US National Institutes of Health
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
SA Rosenberg, NP Restifo, JC Yang, RA Morgan, ME Dudley
Nature Reviews Cancer 8 (4), 299-308, 2008
Mandati: US National Institutes of Health
Adoptive immunotherapy for cancer: harnessing the T cell response
NP Restifo, ME Dudley, SA Rosenberg
Nature Reviews Immunology 12 (4), 269-281, 2012
Mandati: US National Institutes of Health
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
LA Johnson, RA Morgan, ME Dudley, L Cassard, JC Yang, MS Hughes, ...
Blood, The Journal of the American Society of Hematology 114 (3), 535-546, 2009
Mandati: US National Institutes of Health
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, ...
Journal of Clinical Oncology 26 (32), 5233-5239, 2008
Mandati: US National Institutes of Health
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy
RA Morgan, N Chinnasamy, D Abate-Daga, A Gros, PF Robbins, Z Zheng, ...
Journal of immunotherapy 36 (2), 133-151, 2013
Mandati: US National Institutes of Health
Defining ‘T cell exhaustion’
CU Blank, WN Haining, W Held, PG Hogan, A Kallies, E Lugli, RC Lynn, ...
Nature Reviews Immunology 19 (11), 665-674, 2019
Mandati: US National Institutes of Health, National Health and Medical Research …
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
MR Parkhurst, JC Yang, RC Langan, ME Dudley, DAN Nathan, ...
Molecular Therapy 19 (3), 620-626, 2011
Mandati: US National Institutes of Health
Human memory T cells: generation, compartmentalization and homeostasis
DL Farber, NA Yudanin, NP Restifo
Nature Reviews Immunology 14 (1), 24-35, 2014
Mandati: US National Institutes of Health
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
L Gattinoni, XS Zhong, DC Palmer, Y Ji, CS Hinrichs, Z Yu, C Wrzesinski, ...
Nature medicine 15 (7), 808-813, 2009
Mandati: US National Institutes of Health
Tumor-specific Th17-polarized cells eradicate large established melanoma
P Muranski, A Boni, PA Antony, L Cassard, KR Irvine, A Kaiser, ...
Blood, The Journal of the American Society of Hematology 112 (2), 362-373, 2008
Mandati: US National Institutes of Health
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
SA Quezada, TR Simpson, KS Peggs, T Merghoub, J Vider, X Fan, ...
Journal of Experimental Medicine 207 (3), 637-650, 2010
Mandati: Howard Hughes Medical Institute, Canadian Institutes of Health Research
T helper 17 cells promote cytotoxic T cell activation in tumor immunity
N Martin-Orozco, P Muranski, Y Chung, XO Yang, T Yamazaki, S Lu, ...
Immunity 31 (5), 787-798, 2009
Mandati: US National Institutes of Health
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
M Sukumar, J Liu, Y Ji, M Subramanian, JG Crompton, Z Yu, ...
The Journal of clinical investigation 123 (10), 4479-4488, 2013
Mandati: US National Institutes of Health
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1–reactive T-cell receptor: long-term follow-up and correlates with response
PF Robbins, SH Kassim, TLN Tran, JS Crystal, RA Morgan, SA Feldman, ...
Clinical Cancer Research 21 (5), 1019-1027, 2015
Mandati: US National Institutes of Health
Identification of essential genes for cancer immunotherapy
SJ Patel, NE Sanjana, RJ Kishton, A Eidizadeh, SK Vodnala, M Cam, ...
Nature 548 (7669), 537-542, 2017
Mandati: US National Institutes of Health
Complete regression of metastatic cervical cancer after treatment with human papillomavirus–targeted tumor-infiltrating T cells
S Stevanović, LM Draper, MM Langhan, TE Campbell, ML Kwong, ...
Journal of Clinical Oncology 33 (14), 1543-1550, 2015
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software